Stockreport

Edgewise Therapeutics Strengthens Leadership Team to Support Late-Stage Clinical Development

Edgewise Therapeutics, Inc.  (EWTX) 
PDF - Robert Blaustein, M.D., Ph.D. appointed as Chief Development Officer (CDO) -- Behrad Derakhshan, Ph.D. promoted to Chief Operating Officer (COO) - BOULDER, Colo.--( [Read more]